<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8" /><script type="text/javascript">window.NREUM||(NREUM={}),__nr_require=function(e,n,t){function r(t){if(!n[t]){var o=n[t]={exports:{}};e[t][0].call(o.exports,function(n){var o=e[t][1][n];return r(o||n)},o,o.exports)}return n[t].exports}if("function"==typeof __nr_require)return __nr_require;for(var o=0;o<t.length;o++)r(t[o]);return r}({1:[function(e,n,t){function r(){}function o(e,n,t){return function(){return i(e,[c.now()].concat(u(arguments)),n?null:this,t),n?void 0:this}}var i=e("handle"),a=e(2),u=e(3),f=e("ee").get("tracer"),c=e("loader"),s=NREUM;"undefined"==typeof window.newrelic&&(newrelic=s);var p=["setPageViewName","setCustomAttribute","setErrorHandler","finished","addToTrace","inlineHit","addRelease"],d="api-",l=d+"ixn-";a(p,function(e,n){s[n]=o(d+n,!0,"api")}),s.addPageAction=o(d+"addPageAction",!0),s.setCurrentRouteName=o(d+"routeName",!0),n.exports=newrelic,s.interaction=function(){return(new r).get()};var m=r.prototype={createTracer:function(e,n){var t={},r=this,o="function"==typeof n;return i(l+"tracer",[c.now(),e,t],r),function(){if(f.emit((o?"":"no-")+"fn-start",[c.now(),r,o],t),o)try{return n.apply(this,arguments)}finally{f.emit("fn-end",[c.now()],t)}}}};a("setName,setAttribute,save,ignore,onEnd,getContext,end,get".split(","),function(e,n){m[n]=o(l+n)}),newrelic.noticeError=function(e){"string"==typeof e&&(e=new Error(e)),i("err",[e,c.now()])}},{}],2:[function(e,n,t){function r(e,n){var t=[],r="",i=0;for(r in e)o.call(e,r)&&(t[i]=n(r,e[r]),i+=1);return t}var o=Object.prototype.hasOwnProperty;n.exports=r},{}],3:[function(e,n,t){function r(e,n,t){n||(n=0),"undefined"==typeof t&&(t=e?e.length:0);for(var r=-1,o=t-n||0,i=Array(o<0?0:o);++r<o;)i[r]=e[n+r];return i}n.exports=r},{}],4:[function(e,n,t){n.exports={exists:"undefined"!=typeof window.performance&&window.performance.timing&&"undefined"!=typeof window.performance.timing.navigationStart}},{}],ee:[function(e,n,t){function r(){}function o(e){function n(e){return e&&e instanceof r?e:e?f(e,u,i):i()}function t(t,r,o,i){if(!d.aborted||i){e&&e(t,r,o);for(var a=n(o),u=m(t),f=u.length,c=0;c<f;c++)u[c].apply(a,r);var p=s[y[t]];return p&&p.push([b,t,r,a]),a}}function l(e,n){v[e]=m(e).concat(n)}function m(e){return v[e]||[]}function w(e){return p[e]=p[e]||o(t)}function g(e,n){c(e,function(e,t){n=n||"feature",y[t]=n,n in s||(s[n]=[])})}var v={},y={},b={on:l,emit:t,get:w,listeners:m,context:n,buffer:g,abort:a,aborted:!1};return b}function i(){return new r}function a(){(s.api||s.feature)&&(d.aborted=!0,s=d.backlog={})}var u="nr@context",f=e("gos"),c=e(2),s={},p={},d=n.exports=o();d.backlog=s},{}],gos:[function(e,n,t){function r(e,n,t){if(o.call(e,n))return e[n];var r=t();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(e,n,{value:r,writable:!0,enumerable:!1}),r}catch(i){}return e[n]=r,r}var o=Object.prototype.hasOwnProperty;n.exports=r},{}],handle:[function(e,n,t){function r(e,n,t,r){o.buffer([e],r),o.emit(e,n,t)}var o=e("ee").get("handle");n.exports=r,r.ee=o},{}],id:[function(e,n,t){function r(e){var n=typeof e;return!e||"object"!==n&&"function"!==n?-1:e===window?0:a(e,i,function(){return o++})}var o=1,i="nr@id",a=e("gos");n.exports=r},{}],loader:[function(e,n,t){function r(){if(!x++){var e=h.info=NREUM.info,n=d.getElementsByTagName("script")[0];if(setTimeout(s.abort,3e4),!(e&&e.licenseKey&&e.applicationID&&n))return s.abort();c(y,function(n,t){e[n]||(e[n]=t)}),f("mark",["onload",a()+h.offset],null,"api");var t=d.createElement("script");t.src="https://"+e.agent,n.parentNode.insertBefore(t,n)}}function o(){"complete"===d.readyState&&i()}function i(){f("mark",["domContent",a()+h.offset],null,"api")}function a(){return E.exists&&performance.now?Math.round(performance.now()):(u=Math.max((new Date).getTime(),u))-h.offset}var u=(new Date).getTime(),f=e("handle"),c=e(2),s=e("ee"),p=window,d=p.document,l="addEventListener",m="attachEvent",w=p.XMLHttpRequest,g=w&&w.prototype;NREUM.o={ST:setTimeout,SI:p.setImmediate,CT:clearTimeout,XHR:w,REQ:p.Request,EV:p.Event,PR:p.Promise,MO:p.MutationObserver};var v=""+location,y={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",agent:"js-agent.newrelic.com/nr-1039.min.js"},b=w&&g&&g[l]&&!/CriOS/.test(navigator.userAgent),h=n.exports={offset:u,now:a,origin:v,features:{},xhrWrappable:b};e(1),d[l]?(d[l]("DOMContentLoaded",i,!1),p[l]("load",r,!1)):(d[m]("onreadystatechange",o),p[m]("onload",r)),f("mark",["firstbyte",u],null,"api");var x=0,E=e(4)},{}]},{},["loader"]);</script><script type="text/javascript">window.NREUM||(NREUM={});NREUM.info={"beacon":"bam.nr-data.net","queueTime":0,"licenseKey":"cd1101aa94","agent":"","transactionName":"bgcDMkBZW0NZBkdcWVdNJxNcW0FZVwscV1dKB08QW11CQxYTWlBBZgEOC19dW0QCEVtHU1gG","applicationID":"6369297","errorBeacon":"bam.nr-data.net","applicationTime":338}</script>
    <title>Integrating drug target information from BindingDB | Thinklab</title>
	  <link rel="shortcut icon" href="https://think-lab.s3.amazonaws.com/s/img/favicon.ico" type="image/x-icon" />
    <meta property="og:image" content="https://think-lab.s3.amazonaws.com/s/img" />
    
  <link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.6/css/bootstrap.min.css" integrity="sha384-1q8mTJOASx8j1Au+a5WDVnPi2lkFfwwEAa8hDDdjZlpLegxhjVME1fgjWPGmkzs7" crossorigin="anonymous">
  <link rel="stylesheet" href="https://code.jquery.com/ui/1.11.4/themes/smoothness/jquery-ui.css" />

<link rel="stylesheet" href="https://think-lab.s3.amazonaws.com/s/highlightjs/github.css" />
<link rel="stylesheet" href="https://think-lab.s3.amazonaws.com/s/css/css.css" />
<link rel="stylesheet" href="https://think-lab.s3.amazonaws.com/s/css/bootstrap-multiselect.css" />
<!-- <link href='https://fonts.googleapis.com/css?family=Open+Sans:400,700' rel='stylesheet' type='text/css'> -->

    
    
    
    
  
    <meta name="citation_doi" content="10.15363/thinklab.d53">
    <meta name="citation_title" content="Integrating drug target information from BindingDB">
    <meta name="citation_online_date" content="April 13, 2015">
    <meta name="citation_author" content="Daniel Himmelstein, Mike Gilson">
    <meta name="citation_journal_title" content="Thinklab">
    <meta name="citation_publisher" content="Thinklab">
  

    


	<!-- GoogleAnalytics -->
	<script>
	(function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
	(i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
	m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
	})(window,document,'script','//www.google-analytics.com/analytics.js','ga');

	ga('create', 'UA-48550230-1', 'thinklab.com');
	ga('require', 'displayfeatures');
	
	ga('send', 'pageview');

	</script>






</head>
<body >
  <form id="form_action" method="post">
    <input type='hidden' name='csrfmiddlewaretoken' value='pQNiZQX4gF2vyFeXrnbUl9EmuTWA5MG1' />
</form>

	

	<div class="body-wrapper">

		


<!-- <div style="height:5px;background-image:url('https://think-lab.s3.amazonaws.com/s/img/top-bg.gif');"></div> -->
<div class="gradient">
	<div class="main-centered-div header-container">

<table class="full-width" style="height:60px;"><tr>
	<td style="width:200px;vertical-align:middle;padding-bottom:15px;">
		<a href="/" style="font-weight:normal;color:#212121;"><img src="https://think-lab.s3.amazonaws.com/s/img/logo.png" width="160"></a>
	</td><td style="vertical-align:middle;text-align:left;padding-top:6px;width:100%;padding-left:40px;">
		<ul id="not-search-block"  class="main-header">


			


				<li class="dropdown">
					<a class="dropdown-toggle" data-toggle="dropdown" href="#">Browse <span class="caret"></span></a>
					<ul class="dropdown-menu" role="menu">
						<li><a href="/proposals">Proposals</a></li>
						<li><a href="/projects">Projects</a></li>
						<li><a href="/publications">Article discussion</a></li>
						<li><a href="/discussion">All discussion</a></li>
					</ul>
				</li>
				<li><a href="/leaderboard">Leaderboard</a></li>

			
				<li><a href="/about">About</a></li>
			


		</ul>

    <ul id="search-block" class="main-header" style="display: none; margin-right: 30px;">
        <li class="full-width">
            <form method="get" action="/search">
			<div class="input-group full-width">
				<input name="q" type="text" class="form-control search-input">
			</div>
            </form>
        </li>
    </ul>

	</td><td style="vertical-align:middle;text-align:right;padding-top:6px; min-width: 1%; white-space: nowrap;">
		<ul class="main-header pull-right" style="padding-left: 0;">
    		
                <li><a href="/login" style="color:silver;">Login</a></li>
                <li style="margin-right:0"><a class="btn btn-default btn-sm btn-upper" href="/signup">Join</a></li>
            

        </ul>
    </ul>
	</td>
</tr></table>

<!-- <div id="global-search-div" class="main-centered-div" style="display:none;">
	<input type="text" value="" class="thread-search form-control" placeholder="Search" data-action="/discussion">
</div> -->

	</div>
</div>

		
	  



	  


		

		<div class="dark-head"><div class="main-centered-div">

			

		</div></div>
		
		<div class="main-centered-div" style="margin-top:40px;padding-bottom:340px">
	    

<div style="margin-top:-20px; margin-bottom:20px;">

    <a class="side-box" href="/p/rephetio" style="background-color:#ebfdff;"><div class="side-type">Project:</div> <div class="side-title">Rephetio: Repurposing drugs on a hetnet [rephetio]</div></a><br>



    <a class="side-box" href="/doi/10.1093/nar/gkl999" style="background-color:#f0ffec;"><div class="side-type">Publication:</div> <div class="side-title">BindingDB: a web-accessible database of experimentally determined protein-ligand binding affinities</div></a><br>

</div>

<table style="margin-top:0px;"><tr>
	<td class="thread-table-content">

		<table class="full-width">
			
<tr class="comment-tr target-hl" id="1" data-comment-id="133">
  <td class="comment-profile-avatar">
		<a href="/u/dhimmel"><img class='profile_image photo-medium' src='https://think-lab.s3.amazonaws.com/m/profile/17_medium.jpg' width='60' height='60'></a>
  </td>
	<td class="comment-body">
    <a name="133"></a>

    

			<h2 class="page-title" style="margin-bottom:5px;margin-top:0px !important;">Integrating drug target information from BindingDB</h2>

			<div style="margin-top:5px;color:gray;margin-bottom:20px;font-size:13px;">
				<a style="font-weight:normal;color:#212121" href="/u/dhimmel"><strong>Daniel Himmelstein</strong></a>
				<span class="is-researcher">Researcher</span>
				&nbsp; <a href="#1" class="light">816 days ago</a>
				
			</div>

      

          <hr>
		

    <p>We have chosen to rely on <a href="http://www.bindingdb.org/bind/index.jsp">BindingDB</a> <span class="citation">[<a href="https://doi.org/10.1093/nar/gkl999" class="citation" data-key="10.1093/nar/gkl999">1</a>, <a href="https://doi.org/10.2174/1386207013330670" class="citation" data-key="10.2174/1386207013330670">2</a>]</span> for compound–protein binding (ligand–target affinity) information. Their website provides a <a href="http://www.bindingdb.org/bind/BindingDB-Intro2a.pdf">nice background on this topic</a>. BindingDB includes several other databases including ChEMBL <span class="citation">[<a href="https://doi.org/10.1093/nar/gkr777" class="citation" data-key="10.1093/nar/gkr777">3</a>, <a href="https://doi.org/10.1093/nar/gkt1031" class="citation" data-key="10.1093/nar/gkt1031">4</a>]</span> and PubChem BioAssay <span class="citation">[<a href="https://doi.org/10.1093/nar/gkp965" class="citation" data-key="10.1093/nar/gkp965">5</a>, <a href="https://doi.org/10.1093/nar/gkr1132" class="citation" data-key="10.1093/nar/gkr1132">6</a>, <a href="https://doi.org/10.1093/nar/gkt978" class="citation" data-key="10.1093/nar/gkt978">7</a>]</span> and <a href="https://www.bindingdb.org/bind/chemsearch/marvin/SDFdownload.jsp?all_download=yes">provides</a> well-annotated data in convenient formats.</p>

<p>We have <a href="http://nbviewer.ipython.org/github/dhimmel/bindingdb/blob/gh-pages/process.ipynb">begun our parsing of BindingDB</a> from the <code>BindingDB_All_2015m3</code> release. We have taken the following steps:</p>

<ol><li>Some binding experiments refer to multichain protein complexes. However, <code>96% = 1073428 / 1115639</code> of experiments assayed a single chain protein. For simplicity, we decided to omit binding to complexes.</li><li>Of the remaining interactions, the protein targets for <code>20% = 215107 / 1073428 </code> did not map to a SwissProt identifier and were excluded.</li><li>Of the remaining interactions <code>78% = 673750 / 858321</code> were curated with <code>Homo sapiens</code> as the organism. While we will most likely only end up using the human targets, this filtering should naturally occur at a later stage.</li></ol>

<p>The next step is translating BindingDB compounds to DrugBank compounds. Many BindingDB compounds may match a single DrugBank compound. Additionally multiple experiments may report affinities for the same compound–target pair. There are several affinity metrics (<code>Ki (nM)</code>, <code>IC50 (nM)</code>, <code>Kd (nM)</code>, <code>EC50 (nM)</code>) that are in nanomolar units. We would like to combine all affinities for a DrugBank–EntrezGene pair into a single molarity value (which can then be used as a network inclusion threshold).</p>

<p>We would like input on how to combine affinities across experiments. Are some molarity measurements more precise? Are certain source databases less error prone? We are looking for simple and rational rules and are willing to accept a healthy dose of reductionism.</p>

		<div style="margin-left:30px;">

      


      <ul class="comment-notes">
				
				
			</ul>

      

		</div>

		


  </td>
</tr>

<tr class="comment-tr target-hl" id="2" data-comment-id="135">
  <td class="comment-profile-avatar">
		<a href="/u/mkgilson"><img class='profile_image photo-medium' src='https://think-lab.s3.amazonaws.com/s/img/p_default_medium.png' width='60' height='60'></a>
  </td>
	<td class="comment-body">
    <a name="135"></a>

    

      <div class="comment-header">
        <a style="font-weight:bold;color:#212121" href="/u/mkgilson">Mike Gilson</a>
				
				<span class="light">&nbsp;<a href="#2" class="light">815 days</a>
          
        </span>
      </div>

    

    <p>Hi Daniel,</p>

<p>Most of the data in bindingDB are 50% inhibitor concentrations (IC50s), inhibition constants (Kis), with occasional dissocation constants (Kds), all in default units of nanomolar (nM).  The IC50 values are regarded as less rigorous measures of binding affinity as they depend to some degree on the association constant of the enzyme substrate used in measuring the IC50 value. The Ki and Kd values should be somewhat more rigorous. If a given compound and protein target have multiple measurements of different types, I'd probably use them in the following order of preference: Kd over Ki over IC50.  That said, most of the data are IC50s, so this case won't arise all that often.  </p>

<p>Hope this helps!<br>Regards,<br>Mike</p>

		<div style="margin-left:30px;">

      


      <ul class="comment-notes">
				
				
			</ul>

      

		</div>

		


  </td>
</tr>

<tr class="comment-tr target-hl" id="3" data-comment-id="136">
  <td class="comment-profile-avatar">
		<a href="/u/dhimmel"><img class='profile_image photo-medium' src='https://think-lab.s3.amazonaws.com/m/profile/17_medium.jpg' width='60' height='60'></a>
  </td>
	<td class="comment-body">
    <a name="136"></a>

    

      <div class="comment-header">
        <a style="font-weight:bold;color:#212121" href="/u/dhimmel">Daniel Himmelstein</a>
				<span class="is-researcher">Researcher</span>
				<span class="light">&nbsp;<a href="#3" class="light">815 days</a>
          
        </span>
      </div>

    

    <p>The table below categorizes each binding by the affinity measures reported in bindingDB. Some reports include multiple measures. After filtering multichain and unmapped proteins, the number of bindings per category is reported:</p>

<table class="table markdown-table"><thead><tr><th>IC50 (nM)</th><th>Ki (nM)</th><th>Kd (nM)</th><th>EC50 (nM)</th><th>count</th></tr></thead><tbody><tr><td>-</td><td>-</td><td>-</td><td>-</td><td>881</td></tr><tr><td>IC50</td><td>-</td><td>-</td><td>-</td><td>480,070</td></tr><tr><td>-</td><td>Ki</td><td>-</td><td>-</td><td>245,475</td></tr><tr><td>-</td><td>-</td><td>Kd</td><td>-</td><td>55,044</td></tr><tr><td>-</td><td>-</td><td>-</td><td>EC50</td><td>74,549</td></tr><tr><td>IC50</td><td>Ki</td><td>-</td><td>-</td><td>985</td></tr><tr><td>IC50</td><td>-</td><td>Kd</td><td>-</td><td>76</td></tr><tr><td>IC50</td><td>-</td><td>-</td><td>EC50</td><td>631</td></tr><tr><td>-</td><td>Ki</td><td>Kd</td><td>-</td><td>4</td></tr><tr><td>-</td><td>Ki</td><td>-</td><td>EC50</td><td>574</td></tr><tr><td>-</td><td>-</td><td>Kd</td><td>EC50</td><td>8</td></tr><tr><td>IC50</td><td>Ki</td><td>Kd</td><td>-</td><td>1</td></tr><tr><td>IC50</td><td>Ki</td><td>-</td><td>EC50</td><td>23</td></tr></tbody></table>

<p>Definitions for reference:</p>

<ul><li>IC50 - half maximal inhibitory concentration</li><li>Kd - dissociation constant</li><li>Ki - inhibitor constant</li><li>EC50 - half maximal effective concentration</li></ul>

<p><a href="/u/mkgilson" class="username">@mkgilson</a>, thanks! What about EC50s, of which there are 74,549 reports? Can we include this information, and if so where should EC50s fall in the preference order? </p>

<p>Also is it possible to infer whether a ligand is an agonist or antagonist based on which measures are reported?</p>

		<div style="margin-left:30px;">

      


      <ul class="comment-notes">
				
				
			</ul>

      

		</div>

		


  </td>
</tr>

<tr class="comment-tr target-hl" id="4" data-comment-id="137">
  <td class="comment-profile-avatar">
		<a href="/u/mkgilson"><img class='profile_image photo-medium' src='https://think-lab.s3.amazonaws.com/s/img/p_default_medium.png' width='60' height='60'></a>
  </td>
	<td class="comment-body">
    <a name="137"></a>

    

      <div class="comment-header">
        <a style="font-weight:bold;color:#212121" href="/u/mkgilson">Mike Gilson</a>
				
				<span class="light">&nbsp;<a href="#4" class="light">815 days</a>
          
        </span>
      </div>

    

    <p>Hi Dan,</p>

<p>I'd significantly downweight or ignore the EC50s, as these are at greatest risk of not corresponding to a confirmed binding reaction.  For example, there might be a compound which binds, or is expected to bind,  a particular protein target; but the measurement done is to expose cells to the compound and report the concentration at which it is "50% effective" (hence EC50) in producing a biological effect supposedly due to binding of the protein target.</p>

<p>Unfortunately, agonism/antagonism is not readily available.</p>

<p>Regards,<br>Mike</p>

		<div style="margin-left:30px;">

      


      <ul class="comment-notes">
				
				
			</ul>

      

		</div>

		


  </td>
</tr>

<tr class="comment-tr target-hl" id="5" data-comment-id="143">
  <td class="comment-profile-avatar">
		<a href="/u/dhimmel"><img class='profile_image photo-medium' src='https://think-lab.s3.amazonaws.com/m/profile/17_medium.jpg' width='60' height='60'></a>
  </td>
	<td class="comment-body">
    <a name="143"></a>

    

      <div class="comment-header">
        <a style="font-weight:bold;color:#212121" href="/u/dhimmel">Daniel Himmelstein</a>
				<span class="is-researcher">Researcher</span>
				<span class="light">&nbsp;<a href="#5" class="light">813 days</a>
          
        </span>
      </div>

    

    <h1>BindingDB Processing</h1>

<p>For our network, we desire binding edges between entrez genes and drugbank compounds. We coerced the bindingDB to conform to our desires using the following steps:</p>

<h3><a href="https://github.com/dhimmel/bindingdb/blob/95aa588c6e553d85f7bd9030956297076f0df5e3/process.ipynb">Dataset cleanup and tidying</a>:</h3>

<ol><li>downloading and reading bindingDB</li><li>removing interactions with multichain complexes or without uniprot protein IDs</li><li>converting binding affinities to floats</li><li>retrieving entrez genes corresponding to uniprot proteins (<a href="http://git.dhimmel.com/uniprot/data/map/GeneID.tsv.gz">download mapping</a>)</li><li>gathering data so rows contain only a single affinity measurement, uniprot protein, and entrez gene (<a href="https://github.com/dhimmel/bindingdb/blob/95aa588c6e553d85f7bd9030956297076f0df5e3/data/binding.tsv.gz">download tidied data</a>)</li></ol>

<h3><a href="https://htmlpreview.github.io/?https://github.com/dhimmel/bindingdb/blob/95aa588c6e553d85f7bd9030956297076f0df5e3/collapse.html">Collapsing bindingDB into compound-gene relationships</a>:</h3>

<ol><li>restricting to human interactions</li><li>mapping bindingDB compounds to drugbank (<a href="http://git.dhimmel.com/drugbank/data/mapping/bindingdb.tsv">download fuzzy mapping</a>)</li><li>multiple affinities for the same bindingdb–uniprot pairs were resolved by preferentially selecting Kd over Ki over IC50 and taking a geometric mean when there were multiple measurements of the same measure (<a href="https://github.com/dhimmel/bindingdb/blob/95aa588c6e553d85f7bd9030956297076f0df5e3/data/bindings-drugbank-collapsed.tsv">download</a>)</li><li>collapsing into drugbank–gene pairs, taking the minimum affinity reported across grouped bindingdb–uniprot pairs (<a href="https://github.com/dhimmel/bindingdb/blob/95aa588c6e553d85f7bd9030956297076f0df5e3/data/bindings-drugbank-gene.tsv">download</a>)</li></ol>

<p>The resulting drugbank–gene dataset contained 21,617 interactions. Setting an affinity threshold at 1 micromolar (1000 nanomolar) — a threshold suggested by both <a href="/u/mkgilson" class="username">@mkgilson</a> and <a href="/u/alessandrodidonna" class="username">@alessandrodidonna</a> in conversation — retained ~20% of interactions. After thresholding at 1 micromolar, 890 genes and 1,634 drugbank compounds participated in 5,701 binding interactions.</p>

		<div style="margin-left:30px;">

      


      <ul class="comment-notes">
				
				
			</ul>

      

		</div>

		


  </td>
</tr>

<tr class="comment-tr target-hl" id="6" data-comment-id="549">
  <td class="comment-profile-avatar">
		<a href="/u/dhimmel"><img class='profile_image photo-medium' src='https://think-lab.s3.amazonaws.com/m/profile/17_medium.jpg' width='60' height='60'></a>
  </td>
	<td class="comment-body">
    <a name="549"></a>

    

      <div class="comment-header">
        <a style="font-weight:bold;color:#212121" href="/u/dhimmel">Daniel Himmelstein</a>
				<span class="is-researcher">Researcher</span>
				<span class="light">&nbsp;<a href="#6" class="light">596 days</a>
          
        </span>
      </div>

    

    <h1>Update to October 2015 release</h1>

<p>We updated our analysis <span class="citation">[<a href="https://doi.org/10.5281/zenodo.33987" class="citation" data-key="10.5281/zenodo.33987">1</a>]</span> to the latest BindingDB release (<code>BindingDB_All_2015m10.tsv</code>) and made several implementation <a href="https://github.com/dhimmel/bindingdb/commit/36097bc715420827ffd06dd64e05edf95e75f038">enhancements</a>. Now, our collapsed datasets retain source and pubmed information to help with licensing and attribution.</p>

<p>For more information, see the <a href="https://github.com/dhimmel/bindingdb/blob/28dc70275103a233a2f02024082adcea45102a96/process.ipynb">notebook</a> for processing the BindingDB export, the rmarkdown <a href="https://htmlpreview.github.io/?https://github.com/dhimmel/bindingdb/blob/28dc70275103a233a2f02024082adcea45102a96/collapse.html">output</a> for collapsing to compound–gene relationships, and the data download <a href="https://github.com/dhimmel/bindingdb/tree/28dc70275103a233a2f02024082adcea45102a96/data">directory</a>.</p>

<h2>Issue feedback</h2>

<p>A few issues arose which were not present for <code>BindingDB_All_2015m3.tsv</code>. Paging <a href="/u/mkgilson" class="username">@mkgilson</a>:</p>

<ul><li>Rows 192304–192473 (one indexed) start off with SMILES rather than reactant set IDs.</li><li>Numeric binding affinities could not be extracted for 19 rows.</li></ul>

<p>I recommend switching from the ragged tsv to a format that can handle nested structure, such as json or xml.</p>

		<div style="margin-left:30px;">

      


      <ul class="comment-notes">
				
				
			</ul>

      

		</div>

		


  </td>
</tr>

    		
		</table>

    

    &nbsp;<br>
    <a class="btn btn-primary btn-lg" href="/signup?next=/discussion/integrating-drug-target-information-from-bindingdb/53&suppress_message=1" style>Join to Reply</a>


		<table class="references table-td-5" style="display:none;"><tr><td><a href='/doi/10.1093/nar/gkl999' class='pub-comments tt-right' title='Article comments'>6</a></td><td><div class='pub-order'>1.</div></td><td><div class='doi-body' data-key='10.1093/nar/gkl999'><a href='/doi/10.1093/nar/gkl999' class='pub-title'>BindingDB: a web-accessible database of experimentally determined protein-ligand binding affinities</a><div class='pub-body'>T. Liu, Y. Lin, X. Wen, R. N. Jorissen, M. K. Gilson (2007) <i>Nucleic Acids Research</i>. doi:<a class='pub-doi' href='https://doi.org/10.1093/nar/gkl999'>10.1093/nar/gkl999</a></div></div></td></tr><tr><td><a href='/doi/10.2174/1386207013330670' class='pub-comments tt-right zero-items' title='Article comments'>0</a></td><td><div class='pub-order'>2.</div></td><td><div class='doi-body' data-key='10.2174/1386207013330670'><a href='/doi/10.2174/1386207013330670' class='pub-title'>BindingDB: A Web-Accessible Molecular Recognition Database</a><div class='pub-body'>Xi Chen, Ming Liu, Michael Gilson (2001) <i>Combinatorial Chemistry &amp; High Throughput Screening</i>. doi:<a class='pub-doi' href='https://doi.org/10.2174/1386207013330670'>10.2174/1386207013330670</a></div></div></td></tr><tr><td><a href='/doi/10.1093/nar/gkr777' class='pub-comments tt-right zero-items' title='Article comments'>0</a></td><td><div class='pub-order'>3.</div></td><td><div class='doi-body' data-key='10.1093/nar/gkr777'><a href='/doi/10.1093/nar/gkr777' class='pub-title'>ChEMBL: a large-scale bioactivity database for drug discovery</a><div class='pub-body'>A. Gaulton, L. J. Bellis, A. P. Bento, J. Chambers, M. Davies, A. Hersey, Y. Light, S. McGlinchey, D. Michalovich, B. Al-Lazikani, J. P. Overington (2011) <i>Nucleic Acids Research</i>. doi:<a class='pub-doi' href='https://doi.org/10.1093/nar/gkr777'>10.1093/nar/gkr777</a></div></div></td></tr><tr><td><a href='/doi/10.1093/nar/gkt1031' class='pub-comments tt-right zero-items' title='Article comments'>0</a></td><td><div class='pub-order'>4.</div></td><td><div class='doi-body' data-key='10.1093/nar/gkt1031'><a href='/doi/10.1093/nar/gkt1031' class='pub-title'>The ChEMBL bioactivity database: an update</a><div class='pub-body'>A. P. Bento, A. Gaulton, A. Hersey, L. J. Bellis, J. Chambers, M. Davies, F. A. Kruger, Y. Light, L. Mak, S. McGlinchey, M. Nowotka, G. Papadatos, R. Santos, J. P. Overington (2013) <i>Nucleic Acids Research</i>. doi:<a class='pub-doi' href='https://doi.org/10.1093/nar/gkt1031'>10.1093/nar/gkt1031</a></div></div></td></tr><tr><td><a href='/doi/10.1093/nar/gkp965' class='pub-comments tt-right zero-items' title='Article comments'>0</a></td><td><div class='pub-order'>5.</div></td><td><div class='doi-body' data-key='10.1093/nar/gkp965'><a href='/doi/10.1093/nar/gkp965' class='pub-title'>An overview of the PubChem BioAssay resource</a><div class='pub-body'>Y. Wang, E. Bolton, S. Dracheva, K. Karapetyan, B. A. Shoemaker, T. O. Suzek, J. Wang, J. Xiao, J. Zhang, S. H. Bryant (2009) <i>Nucleic Acids Research</i>. doi:<a class='pub-doi' href='https://doi.org/10.1093/nar/gkp965'>10.1093/nar/gkp965</a></div></div></td></tr><tr><td><a href='/doi/10.1093/nar/gkr1132' class='pub-comments tt-right zero-items' title='Article comments'>0</a></td><td><div class='pub-order'>6.</div></td><td><div class='doi-body' data-key='10.1093/nar/gkr1132'><a href='/doi/10.1093/nar/gkr1132' class='pub-title'>PubChem&#39;s BioAssay Database</a><div class='pub-body'>Y. Wang, J. Xiao, T. O. Suzek, J. Zhang, J. Wang, Z. Zhou, L. Han, K. Karapetyan, S. Dracheva, B. A. Shoemaker, E. Bolton, A. Gindulyte, S. H. Bryant (2011) <i>Nucleic Acids Research</i>. doi:<a class='pub-doi' href='https://doi.org/10.1093/nar/gkr1132'>10.1093/nar/gkr1132</a></div></div></td></tr><tr><td><a href='/doi/10.1093/nar/gkt978' class='pub-comments tt-right zero-items' title='Article comments'>0</a></td><td><div class='pub-order'>7.</div></td><td><div class='doi-body' data-key='10.1093/nar/gkt978'><a href='/doi/10.1093/nar/gkt978' class='pub-title'>PubChem BioAssay: 2014 update</a><div class='pub-body'>Y. Wang, T. Suzek, J. Zhang, J. Wang, S. He, T. Cheng, B. A. Shoemaker, A. Gindulyte, S. H. Bryant (2013) <i>Nucleic Acids Research</i>. doi:<a class='pub-doi' href='https://doi.org/10.1093/nar/gkt978'>10.1093/nar/gkt978</a></div></div></td></tr><tr><td><a href='/doi/10.5281/zenodo.33987' class='pub-comments tt-right zero-items' title='Article comments'>0</a></td><td><div class='pub-order'>8.</div></td><td><div class='doi-body' data-key='10.5281/zenodo.33987'><a href='/doi/10.5281/zenodo.33987' class='pub-title'>Processing the October 2015 BindingDB</a><div class='pub-body'>Daniel Himmelstein, Michael Gilson, Sergio Baranzini (2015) <i>Zenodo</i>. doi:<a class='pub-doi' href='https://doi.org/10.5281/zenodo.33987'>10.5281/zenodo.33987</a></div></div></td></tr></table>

    


	</td>
	<td class="thread-sidebar">


			

      <a class="btn btn-default follow-link btn-follow btn-lg is-following tt-top full-width" title="Follow discussion" data-id="53" data-ctype="thread" data-is-following="false">&nbsp;</a>

      
        <div class="status-box text-center"><span style="">Status:</span> 
  Completed

</div>
      

      
        
      


				

					<div class="details">Views</div>
					<span style="font-size:20px;">297</span>

        

				
					<div class="details">Topics</div>
					<div style="margin-bottom:15px;">
		            <a href="/topics/databases" class="tag">Databases</a><a href="/topics/compounds" class="tag">Compounds</a><a href="/topics/bindingdb" class="tag">BindingDB</a><a href="/topics/drug-targets" class="tag">Drug Targets</a><a href="/topics/chembl" class="tag">ChEMBL</a><a href="/topics/pubchem-bioassay" class="tag">PubChem BioAssay</a><a href="/topics/affinity" class="tag">Affinity</a><a href="/topics/binding-affinity" class="tag">Binding Affinity</a>
					</div>
				


		
			<div class="details">Referenced by</div>
			<div style="font-size:12px;"><ul style="padding-left:16px !important;">
			
				<li>
					
					<a href='/discussion/integrating-resources-with-disparate-licensing-into-an-open-network/107' class='thread-title'>Integrating resources with disparate licensing into an open network</a>
				</li>
			
				<li>
					
					<a href='/discussion/incorporating-drugcentral-data-in-our-network/186' class='thread-title'>Incorporating DrugCentral data in our network</a>
				</li>
			
				<li>
					
					Research report: <a href='/p/rephetio/report'>Rephetio: Repurposing drugs on a hetnet</a>
				</li>
			
				<li>
					
					<a href='/discussion/text-as-a-resource-for-network-population/48' class='thread-title'>Text as a resource for network population?</a>
				</li>
			
				</ul>
			</div>
		

		
			<div class="details">Cite this as</div>
			<span style="font-size:12px;">
				Daniel Himmelstein, Mike Gilson (2015) Integrating drug target information from BindingDB. <i>Thinklab.</i> doi:<a href='https://doi.org/10.15363/thinklab.d53'>10.15363/thinklab.d53</a>
			</span>
		

		<div class="details">License</div>
		<p><a rel="license" href="http://creativecommons.org/licenses/by/4.0/"><img alt="Creative Commons License" style="border-width:0;width:88px;height:31px;" src="https://i.creativecommons.org/l/by/4.0/88x31.png" /></a></p>

		<div class="details">Share</div>
		
			
				<a class="share-button fb" onclick="javascript:void(window.open('https://www.facebook.com/sharer/sharer.php?u=https%3A//thinklab.com/discussion/integrating-drug-target-information-from-bindingdb/53','','width=600,height=460,menubar=no,status=no'));" href="#"></a>
<a class="share-button twitter" onclick="javascript:void(window.open('https://twitter.com/share?text=Integrating%20drug%20target%20information%20from%20BindingDB&url=https%3A//thinklab.com/discussion/integrating-drug-target-information-from-bindingdb/53','','width=600,height=300,menubar=no,status=no'));" href="#"></a>
<a class="share-button google" onclick="javascript:void(window.open('https://plus.google.com/share?url=https%3A//thinklab.com/discussion/integrating-drug-target-information-from-bindingdb/53','','width=510,height=460,menubar=no,status=no'));" href="#"></a>

			
		

	</td>
</tr></table>


		</div>


		
	    	<div class="footer">
<div style="background:#dedede;">
	<div class="main-centered-div text-center" style="padding:20px;">
		<h4 style="margin-bottom:0px;font-weight:bold;color:gray;">Feedback? Questions? Email us: <a href="/cdn-cgi/l/email-protection#bed6dbd2d2d1fecad6d7d0d5d2dfdc90ddd1d3"><span class="__cf_email__" data-cfemail="026a676e6e6d42766a6b6c696e63602c616d6f">[email&#160;protected]</span><script data-cfhash='f9e31' type="text/javascript">/* <![CDATA[ */!function(t,e,r,n,c,a,p){try{t=document.currentScript||function(){for(t=document.getElementsByTagName('script'),e=t.length;e--;)if(t[e].getAttribute('data-cfhash'))return t[e]}();if(t&&(c=t.previousSibling)){p=t.parentNode;if(a=c.getAttribute('data-cfemail')){for(e='',r='0x'+a.substr(0,2)|0,n=2;a.length-n;n+=2)e+='%'+('0'+('0x'+a.substr(n,2)^r).toString(16)).slice(-2);p.replaceChild(document.createTextNode(decodeURIComponent(e)),c)}p.removeChild(t)}}catch(u){}}()/* ]]> */</script></a></h4>
	</div>
</div>
<div class="main-footer">
	<div class="main-centered-div">

<table class="full-width"><tr>
	<td class="footer-nav">

        <div class="foot-head">Explore</div>
        <a href="/proposals">Proposals</a><br>
        <a href="/projects">Projects</a><br>
        <a href="/publications">Article discussion</a><br>
        <a href="/discussion">All discussion</a><br>
        <a href="/topics">Topics</a><br>
        <!-- <a href="/funders">Funders</a><br> -->
        <a href="/funding">Funding opportunities</a><br>

	</td>
	<td class="footer-nav">

        <!-- <div class="foot-head">Help &amp; feedback</div>	 -->
        <!-- <div class="foot-head">Intro</div>
        <a href="/benefits/for-science">Why</a><br>
        <a href="/how-it-works">How it works</a><br>

<br> -->

        <div class="foot-head">Community</div>
        <a href="/leaderboard">Leaderboard</a><br>
        <a href="/p/meta">Thinklab Meta</a><br>
				<a href="/help/faq">Help</a><br>
				<!-- <a href="/new-project">Start a proposal</a><br> -->
        <!-- <a href="/benefits/proposal">Benefits</a><br> -->
        <!-- <a href="/funding">Get funded</a><br> -->
        <!-- <a href="/participate">Become a contributor</a><br> -->
        <!-- <a href="/for-funders">For science funders</a><br> -->
        <!-- <a href="/for-institutions">For institutions</a><br> -->

	</td>
	<td class="footer-nav">



        <div class="foot-head">About</div>
        <a href="/about">Overview</a><br>
        <a href="/benefits">Benefits</a><br>
        <a href="/how-it-works">How it works</a><br>
        <a href="/about/story">Our story</a><br>
        <a href="/blog">Our blog</a><br>
        <a href="/about/jobs">Join the team</a><br>
        <br>

        <!-- <div class="foot-head">Help</div>
        <a href="/help">Help</a><br>
		 -->


	</td>
	<td class="footer-nav">
		<a href="http://twitter.com/thinklab" class="social-icon"><img src="https://think-lab.s3.amazonaws.com/s/img/icons/twitter_com.png" width="40"/></a>
		<a href="https://www.facebook.com/pages/Thinklab/310895039088185" class="social-icon"><img src="https://think-lab.s3.amazonaws.com/s/img/icons/facebook_com.png" width="40"/></a>
		<a href="https://plus.google.com/115578983466800753402/" class="social-icon"><img src="https://think-lab.s3.amazonaws.com/s/img/icons/plus_google_com.png" width="40"/></a>
		<a href="https://www.linkedin.com/company/thinklab-co" class="social-icon"><img src="https://think-lab.s3.amazonaws.com/s/img/icons/linkedin_com.png" width="40"/></a>
		<br><br>
		<span class="light" style='font-size:12px;'>&copy; 2015 Thinklab</span>

	</td>

</tr></table>

</div>
</div>
</div>

		

	</div>


  <script></script>
  <script>
  var MEDIA_URL = 'https://think-lab.s3.amazonaws.com/m/';
  var STATIC_URL = 'https://think-lab.s3.amazonaws.com/s/';
  var page_is_authenticated = false;
  var page_page = 'discussion';
  var page_profile_id = undefined;
</script>



	<!-- Note different script type. MUST come before MathJax.js -->
	<script type="text/x-mathjax-config">
	    MathJax.Hub.Config({
	        "HTML-CSS": { preferredFont: "TeX", availableFonts: ["STIX","TeX"],
	                        scale: 110, linebreaks: { automatic:true },
	                        EqnChunk: (MathJax.Hub.Browser.isMobile ? 10 : 50) },
	        tex2jax: { inlineMath: [ ["$$", "$$"], ["\\(","\\)"] ],
	                    displayMath: [ ["$$$","$$$"], ["\\[", "\\]"] ],
	                    processEscapes: true,}
	            });

	</script>
    <script src="https://cdn.mathjax.org/mathjax/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>





  <script src="https://code.jquery.com/jquery-1.10.2.min.js"></script>
  <script src="https://code.jquery.com/ui/1.11.4/jquery-ui.min.js"></script>
  <script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.6/js/bootstrap.min.js" integrity="sha384-0mSbJDEHialfmuBBQP6A4Qrprq5OVfW37PRR3j5ELqxss1yVqOtnepnHVP9aJ7xS" crossorigin="anonymous"></script>
  <script src="https://think-lab.s3.amazonaws.com/s/dist/main.min.js"></script>
  



  
	
  
  
  
<script>
$(function() {
  recordHit('thread', 53);
});
</script>



<script>/* <![CDATA[ */(function(d,s,a,i,j,r,l,m,t){try{l=d.getElementsByTagName('a');t=d.createElement('textarea');for(i=0;l.length-i;i++){try{a=l[i].href;s=a.indexOf('/cdn-cgi/l/email-protection');m=a.length;if(a&&s>-1&&m>28){j=28+s;s='';if(j<m){r='0x'+a.substr(j,2)|0;for(j+=2;j<m&&a.charAt(j)!='X';j+=2)s+='%'+('0'+('0x'+a.substr(j,2)^r).toString(16)).slice(-2);j++;s=decodeURIComponent(s)+a.substr(j,m-j)}t.innerHTML=s.replace(/</g,'&lt;').replace(/\>/g,'&gt;');l[i].href='mailto:'+t.value}}catch(e){}}}catch(e){}})(document);/* ]]> */</script></body>
</html>
